Knopman DS - Search Results

1

Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.

Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, Marder KS, Moy CS, Phelps CH, Scott PA, Seeley WW, Sieber BA, Silverberg NB, Sutherland ML, Taylor A, Torborg CL, Waddy SP, Gubitz AK, Holtzman DM. Corriveau RA, et al. Among authors: knopman ds. Neurology. 2017 Dec 5;89(23):2381-2391. doi: 10.1212/WNL.0000000000004717. Epub 2017 Nov 8. Neurology. 2017. PMID: 29117955 Free PMC article. Review.

2

Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group.

DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ, Markesbery WR. DeKosky ST, et al. Among authors: knopman ds. Ann Neurol. 1992 Nov;32(5):625-32. doi: 10.1002/ana.410320505. Ann Neurol. 1992. PMID: 1360195

3

The spectrum of imaging and neuropsychological findings in Pick's disease.

Knopman DS, Christensen KJ, Schut LJ, Harbaugh RE, Reeder T, Ngo T, Frey W 2nd. Knopman DS, et al. Neurology. 1989 Mar;39(3):362-8. doi: 10.1212/wnl.39.3.362. Neurology. 1989. PMID: 2927644

4

Dementia without Alzheimer pathology.

Heilig CW, Knopman DS, Mastri AR, Frey W 2nd. Heilig CW, et al. Among authors: knopman ds. Neurology. 1985 May;35(5):762-5. doi: 10.1212/wnl.35.5.762. Neurology. 1985. PMID: 2986048

5

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

Knopman DS, Knapp MJ, Gracon SI, Davis CS. Knopman DS, et al. Neurology. 1994 Dec;44(12):2315-21. doi: 10.1212/wnl.44.12.2315. Neurology. 1994. PMID: 7991118 Clinical Trial.

6

Alzheimer's disease: a comprehensive approach to patient management.

Bennett DA, Knopman DS. Bennett DA, et al. Among authors: knopman ds. Geriatrics. 1994 Aug;49(8):20-6. Geriatrics. 1994. PMID: 8039725 Review.

7

A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.

Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A. Thal LJ, et al. Neurology. 1996 Dec;47(6):1389-95. doi: 10.1212/wnl.47.6.1389. Neurology. 1996. PMID: 8960716 Clinical Trial.

8

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. Galasko D, et al. Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937. Arch Neurol. 1998. PMID: 9678311 Clinical Trial.

9

Opportunities for improving managed care for individuals with dementia: Part 1--The issues.

Fillit H, Knopman D, Cummings J, Appel F. Fillit H, et al. Am J Manag Care. 1999 Mar;5(3):309-15. Am J Manag Care. 1999. PMID: 10351027 Free article.

10

Opportunities for improving managed care for individuals with dementia: Part 2--A framework for care.

Fillit H, Knopman D, Cummings J, Appel F. Fillit H, et al. Am J Manag Care. 1999 Mar;5(3):317-24. Am J Manag Care. 1999. PMID: 10351028 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,089 results

Search Page

Filters